Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Platelet-rich plasma therapy is versatile and popular for various treatments, including anti-aging.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Baricitinib helps treat severe hair loss in people over 65.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Five monthly sessions of minoxidil-dutasteride-copper peptide tattooing significantly improve hair regrowth in men with androgenetic alopecia.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The traditional treatment was more effective than finasteride for androgenic alopecia.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Six African American women experienced hair loss after switching to a new HIV medication.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.